The estimated Net Worth of James E Oliff is at least $10.9 Milión dollars as of 15 July 2016. James Oliff owns over 1,000 units of CME Inc stock worth over $7,816,997 and over the last 21 years James sold CME stock worth over $3,044,044.
James has made over 19 trades of the CME Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently James sold 1,000 units of CME stock worth $102,300 on 15 July 2016.
The largest trade James's ever made was selling 3,300 units of CME Inc stock on 19 September 2005 worth over $1,009,866. On average, James trades about 320 units every 121 days since 2003. As of 15 July 2016 James still owns at least 35,761 units of CME Inc stock.
You can see the complete history of James Oliff stock trades at the bottom of the page.
James's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at CME Inc have traded over $264,111,034 worth of CME Inc stock and bought 77,667 units worth $15,169,350 . The most active insiders traders include Terrence A Duffy, Phupinder Gill a Bryan T Durkin. On average, CME Inc executives and independent directors trade stock every 10 days with the average trade being worth of $863,868. The most recent stock trade was executed by Bryan T Durkin on 30 August 2024, trading 7,593 units of CME stock currently worth $1,629,382.
as the world's leading and most diverse derivatives marketplace, cme group (www.cmegroup.com) is where the world comes to manage risk. cme group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. cme group brings buyers and sellers together through its cme globex® electronic trading platform and its trading facilities in new york and chicago. cme group also operates cme clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through cme clearport®. these products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.
CME Inc executives and other stock owners filed with the SEC include: